Advanced oxidation process (AOPs) based on sulfate radical (SO4●−) and singlet oxygen (1O2) has attracted a lot of attention because of its characteristics of rapid reaction, efficient treatment, safety and stability, and easy operation. SO4●− and 1O2 mainly comes from the activation reaction of peroxymonosulfate (PMS) or persulfate (PS), which represent the oxidation reactions involving radicals and non-radicals, respectively. The degradation effects of target pollutants will be different due to the type of oxidant, reaction system, activation methods, operating conditions, and other factors.
Properties | PS (Take Potassium Persulfate as an Example) | PMS (Take Potassium Peroxymonosulfate as an Example) |
---|---|---|
CAS Registry Number | 7727-21-1 | 10058-23-8 |
Chemical formula | K2S2O8 | KHSO5 |
Molecular mass | 270.309 | 614.738 |
Solubility in water (20 °C) | 520 g/L | >250 g/L |
Redox potential | 2.01 V | 1.82 V |
Reaction System | Pollutant | Conditions | Reactivity | Dominant ROS | Ref. |
---|---|---|---|---|---|
UV(254 nm)/PMS | benzoic acid (BA) | [BA] = 9.90 μM; [PMS] = 100 μM as 1/2 Oxone; pH = 11. |
>90% with 10 min | SO4●− and ●OH | [18] |
UV(254 nm)/PS | Chlorophene | [Chlorophene] = 1 μM, [PS] = 50 μM, pH = 7, UV intensity (254 nm,15 W) = 4.23 mWcm−2. | 100% with 5 min | SO4●− | [19] |
UV-C laser/PS | Iohexol (IOX) | IUV = 25 mW/cm2, [PS] = 1.0 mM, [IOX] = 10 μM, initial pH = 7.0 ± 0.5, temperature 25 °C. | 93.8% within only 40 s | SO4●− | [20] |
Heat/PS | Ibuprofen (IBU) | [phosphate buffer] = 0.09 M, pH = 7.0, [IBU] = 20.36 μM, [PS] = 1.0 mM, T = 70 °C. | 100% with 20 min | SO4●− and ●OH | [21] |
Heat/PS | 1-alkyl-3-methylimidazolium bromides (C4mimBr) | [C4mimBr] = 0.1 mM, [PS] = 10 mM, T = 60 °C, pH = 7, V = 100 mL. | 100% with 120 min | SO4●− | [22] |
Ultrasound/PS | 1,1,1-trichloroethane (TCA) | [TCA] = 25.0 mg/L, [PS] = 250.0 mg/L pH 7.0, T = 20 ± 2 °C, ultrasound: 400 kHz, 100 W. | 100% with 120 min | SO4●− | [23] |
Electrolysis(boron-doped diamond anode)/PS | Ampicillin | [Ampicillin] = 1.1 mg/L, [PS] = 250 mg/L, current density (BDD anode) = 25 mAcm−2. | 100% with 120 min | SO4●− and ●OH | [24] |
Fe0/PS | sulfamethoxazole (SMX) | [SMX] = 39.5 μM, [PS] = 1.0 mM, [Fe0] = 2.23 mM; m (Fe0) = 2.5 mg, pH = 3.52. | 100% with 30 min | SO4●− | [25] |
Fe2+/PS | Acetaminophen (ACT) | [ACT] = 0.05 mM, [Fe2+] = 1 mM, [PS] = 0.8 mM, pH = 3, T = 20 °C. | 70% with 30 min | SO4●− | [26] |
Fe(II)/PMS | 2-chlorobiphenyl (2-CB) | [2-CB] = 0.0212 mM; [Fe(II)] = 0.11 mM; [PMS]0 = 0.11 mM. | 90% with 240 min | SO4●− | [27] |
Co2+/PMS | nuclear grade cationic IRN-77 resin | initial pH = 9, [Co2+] = 4 mM, [PMS] = 60 mM T = 60 °C. | ∼90% COD removal (1000 mg/L) with 60 min | SO4●− and ●OH | [28] |
Cu2+/PMS | Triclosan (TCS) | [TCS] = 9 mg/L (0.031 mM), initial pH = 7, molar ratio of oxidant to metal = 1:1, molar ratio of oxidant to triclosan = 5:1. | 95% with 10 min | SO4●− | [29] |
Ru3+/PMS | 2,4-dichlorophenol (2,4-DCP) | [2,4-DCP] = 0.311 mM, [RuCl3·xH2O] = 2.553 mM, [KHSO5] = 1.244 mM, pH = 7. | 98% in less than 1 min | SO4●− | [30] |
Natural chalcopyrite/PMS | Bisphenol S | Bisphenol S = 25 μM, chalcopyrite = 2 g/L, PMS = 0.4 mM, initial pH = 6.2, T = 303 K. | 83% with 30 min | SO4•− and •OH | [31] |
Eggshell-loaded CoFe2O4./PMS | Florfenicol (FF) | CoFe2O4/eggshell = 0.4 g/L, [PMS] = 0.96 mmol/L, [FF] = 10 mg/L, T = 30 °C, initial pH = 6.61. | 96.8% within 40 min | SO4•– and •OH | [32] |
CoFe layered double oxide/g-C3N4/PMS | paracetamol | [catalyst] = 0.2 g/L, [PMS] = 0.5 mM, [paracetamol] = 10 mg/L, temperature = 25 ± 0.5 °C, initial pH = 7 ± 0.2. | 100% in less than 10 min | SO4●− | [33] |
Co3O4/PMS | Acid Orange 7 | [AO7] = 0.2 mM, [PMS] = 2 mM and [nano-Co3O4] = 0.5 g/L, pH = 7. | 100% with 60 min | SO4●− | [34] |
Co-MCM41 | Caffeine (CAF) | [CAF] = 0.05 mM, [PMS] = 0.2 mM, [catalyst] = 200 mg/L, pH = 7.10. | 100% with 15 min | SO4•– and •OH | [35] |
Ag0.4-BiFeO3/PS | tetracycline (TC) | [catalysts] = 300 mg/L, [PS] = 5 mM, [TC] = 10 mg/L, pH = 4.5, T = 298 K. | 91% with 60 min | SO4●− and ●OH | [36] |
S-doped α-Fe2O3/PS | carbamazepine (CBZ) | [CBZ] = 2 mg/L, [PS]0 = 0.2 mM, [catalyst] = 0.2 g/L, T = 25 ± 1 °C and initial pH = 6.8 ± 0.5. | 93.13% with 30 min | SO4●− | [37] |
Fe3O4@Zn/Co-ZIFs/PMS | carbamazepine (CBZ) | [CBZ] = 5 mg/L, [catalyst] = 25 mg/L, [PMS] = 0.4 mM, initial pH = 6.8, T = 30 °C. | 100% with 30 min | SO4●− | [38] |
Co3O4/C-BC/PMS | Bisphenol A (BPA) | [catalyst] = 0.3 g/L, [pollutant] = 20 mg/L, [PMS] = 1.0 mmol/L, [pH] = 7.0, [T] = 30 °C. | 100% within less than 30 min | SO4●− | [39] |
ZnO/biochar/PS | tetracycline hydrochloride (TC) | [TC] = 0.05 g/L, [ZnO200/BC] = 0.1 g/L, [PS] = 1.0 mM, pH = 7.0 ± 0.1, T = 25 ± 2 °C. | 44.98% with 50 min | SO4●− and ●OH | [40] |
microwave irradiation(MW)/CuO/PS | 2,4-dichlorophenol (2,4-DCP) | [PS] = 0.4 g/L, [CuO] = 40 mg/L, (2,4-DCP) = 50 mg/L, initial pH = 9, MW power intensity = 180 W. | >98% with 90 min | SO4●− | [41] |
Ultrasound/Fe0/PS | Sulfadiazine (SD) | [SD] = 20 mg/L, [Fe0] = 0.92 Mm, [PS] = 1.84 mM, US input power = 90 W, initial pH = 7, room temperature. | 99.1% with 60 min | SO4●− | [42] |
granular activated carbon (GAC)/PMS | Acid Orange 7 (AO7) | [AO7] = 20 mg/L, [PMS]: [AO7] = 100:1, [GAC] = 1.0 g/L, without pH adjustment, T = 20 ± 0.5 °C. | 85% with 5 h | SO4●− | [43] |
Fe3O4@Graphene oxide (GO)/PS | Rhodamine B (RhB) | [RhB] = 20 ppm, [Fe3O4@GO] = 500 mg/L, [PS] = 1.5 mM, pH = 4.34, T = 20 °C. | 89% with 120 min | SO4●− | [44] |
alkali and CuO/PS | Cu-ethylenediamine tetraacetic acid (Cu(II)-EDTA) | [Cu(II)-EDTA] = 3.14 mM, [PS]/[Cu(II)-EDTA] = 15:1, [CuO] = 2 g/L, pH maintained at 11. | Nearly 100% with 120 min | SO4•−, •OH and O2•− | [45] |
This entry is adapted from the peer-reviewed paper 10.3390/catal12101092